Statistics

Total Visits

Views
Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 9801335

Select a period of time:

Number of views in the range

Views
Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 9801317

Views

Views
February 20250
March 20250
April 20252
May 20251
June 20250
July 202514
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil6
United States5
Colombia1
Germany1
Spain1
United Kingdom1
Jamaica1
South Africa1
 

Top cities views

Views
Aguachica1
Council Bluffs1
Garibaldi1
Goiânia1
Montego Bay1
Munich1
Pretoria1
Riachão das Neves1
Ridgeland1
Shrewsbury1